← Eichor
Condition: Biomarker In Early Diagnosis Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Biomarker In Early Diagnosis

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Screening Nasopharyngeal Carcinoma With EBV Associated Biomarkers in Zhongshan City
Phase N/A · 2 location(s) · Zhongshan People's Hospital, Guangdong, China · NCT04085900
miR-342-5p/AnkG Pathway in Early AD Synaptic Dysfunction
NA · 1 location(s) · The Fourth Affiliated Hospital of Zhejiang University School · NCT07353502
Sepsis Multiomic Analysis & Risk sTratification in China
Phase N/A · 1 location(s) · Yuebei People's Hospital · NCT07599644
Application Research of Methylation Markers in Early-stage Lung Cancer Patients Treated With Co-ablation System Therapy
Phase N/A · 1 location(s) · Beijing Haidian Hospital · NCT07257471
Impairments of Neuro-muscular Communication in Motor-Neuron Disease: A Bio-Marker for Early and Personalised Diagnosis
Phase N/A · 1 location(s) · University of Dublin, Trinity College · NCT05663008
DYNAMIC-UC: Early qFIT and Calprotectin Change Predicting Relapse in Biologic-Naive Ulcerative Colitis
Phase N/A · 1 location(s) · Qilu Hospital of Shandong University · NCT07111273
Generating Intervals of Reference FFor Early Life Brain Biomarkers.
Phase N/A · 1 location(s) · University College Cork · NCT07585149
Evaluation of [68Ga]Ga-NOTA-anti-HER2-sdAb PET/CT for Predicting Pathological Complete Response After Neoadjuvant Chemot
Phase 2 · 1 location(s) · Centre Henri Becquerel · NCT07593976
Study of Early Cancer Biomarkers in Breath Condensate in Population of Individuals With High-Risk of Lung Cancer Undergo
NA · 3 location(s) · The Institute of Molecular and Translational Medicine, Czech · NCT06016569
Identification and Validation of Blood-Based Biomarkers for Early Detection of Asymptomatic Lung Cancer in High-Risk Hea
Phase N/A · 1 location(s) · Everest Detection, Inc. · NCT06816121
Synovial Tissue as a Biomarker in the Early Management of Osteoarthritis
NA · 2 location(s) · Nantes University Hospital · NCT07473414
Development of a Database to Investigate Digital and Blood-Based Biomarkers and Their Relationship to Tau and Amyloid PE
Phase N/A · 26 location(s) · GAP Innovations, PBC · NCT06584357
Signatera-Guided CDK4/6 Inhibitor Therapy in Breast Cancer
NA · 39 location(s) · Natera, Inc. · NCT07214532
Olfactory Testing in Perinatal Asphyxia: Enhancing Risk Assessment
Phase N/A · 1 location(s) · University of Parma · NCT06744244
A Multi-omic Approach to the Identification of Novel Biomarkers in Early Charcot-Marie-Tooth 1A Disease (CMT1A)
Phase N/A · 1 location(s) · University Medical Center Goettingen · NCT07476365
An Observational Study on Lecanemab Treatment for Early Alzheimer's Disease
Phase N/A · 2 location(s) · First Affiliated Hospital of Zhejiang University · NCT07153848
Interest of the Chair Lift Test in the Prognostic Evaluation of Pulmonary Embolism: a Single-center Open Prospective Stu
NA · 1 location(s) · University Hospital, Rouen · NCT06166329
Biobank for the Identification of Biomarkers in Lung Cancer (BIRD, Biomarkers in Respiratory Disease)
Phase N/A · 1 location(s) · University Hospital, Toulouse · NCT06054854
Fecal biOmarker Response Evaluation for Super-Early Efficacy in Ulcerative Colitis
Phase N/A · 1 location(s) · Qilu Hospital of Shandong University · NCT07111572
Heart CT Imaging to Detect Early Coronary Artery Disease in First-Degree Relatives With High or Low Lipoprotein(a) Ident
Phase N/A · 1 location(s) · E.S.stroes · NCT06995183
Exogenous and Endogenous Risk Factors for Early-onset Colorectal Cancer
Phase N/A · 8 location(s) · San Raffaele University · NCT05732623
Discovery and Validation of Periodontitis Biomarkers
Phase N/A · 1 location(s) · Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao · NCT07293481
CARE-CRC: Microbiome Insights and Correlations for Risk and Outcomes in Colorectal Cancer
Phase N/A · 2 location(s) · Gulbenkian Institute for Molecular Medicine · NCT06734156
New bioMarkers tO straTIfy cOlorectal caNcer Referrals
Phase N/A · 1 location(s) · Queen Mary University of London · NCT07035691
Blood Based Risk Evaluation With AI for Targeted Primary Health Care in Early Lung Cancer Detection
NA · 2 location(s) · Vejle Hospital · NCT07552584
Marker - Adjusted Therapy Comparing Adjuvant Elacestrant With Standard Endocrine Treatment in Genomically and/or Clinica
Phase 3 · 1 location(s) · West German Study Group · NCT07242352
Biomarkers Study in Infants With Prior Neonatal Brain Injury
Phase N/A · 1 location(s) · University of Wisconsin, Madison · NCT07413900
Application of Methylation Markers in Early Detection and MRD Monitoring of Lung Cancer
Phase N/A · 1 location(s) · Beijing Haidian Hospital · NCT07257458
Early Psychosis: Investigating Cognition
NA · 1 location(s) · University of Nottingham · NCT07196423
Efficacy of Esmolol in the Identification of Cardiovascular Disorders by Cirrhosis, Diabetes Mellitus and Cardiotoxic Tr
Phase 3 · 6 location(s) · Consorcio Centro de Investigación Biomédica en Red (CIBER) · NCT05769868
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.